Cargando…
Sirolimus-induced secondary pulmonary alveolar proteinosis
Pulmonary alveolar proteinosis (PAP) is a rare pulmonary syndrome that is characterized by the accumulation of excess surfactant in the alveolar space, leading to impaired gas exchange. Sirolimus-induced PAP is an extremely rare entity that has only been described in the literature in a small number...
Autores principales: | Wang, Stephanie, Lee, Elinor, Lau, Ryan, Wang, Tisha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688701/ https://www.ncbi.nlm.nih.gov/pubmed/34976718 http://dx.doi.org/10.1016/j.rmcr.2021.101566 |
Ejemplares similares
-
Reversible sirolimus-induced pulmonary alveolar proteinosis in a renal transplant patient
por: Hinojosa-González, David Eugenio, et al.
Publicado: (2020) -
Congenital Pulmonary Alveolar Proteinosis
por: Hammami, Saber, et al.
Publicado: (2013) -
Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis
por: McCarthy, Cormac, et al.
Publicado: (2018) -
The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review
por: Ataya, Ali, et al.
Publicado: (2021) -
Pulmonary alveolar proteinosis in a cat
por: Szatmári, Viktor, et al.
Publicado: (2015)